Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
American Tower
AMT
|
$259M |
| 2 |
Pfizer
PFE
|
$177M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$163M |
| 4 |
Amazon
AMZN
|
$161M |
| 5 |
DuPont de Nemours
DD
|
$149M |
Top Sells
| 1 |
LNCE
Snyders-Lance, Inc.
LNCE
|
$179M |
| 2 |
ASGN Inc
ASGN
|
$176M |
| 3 |
CAA
CalAtlantic Group, Inc.
CAA
|
$175M |
| 4 |
CPN
Calpine Corporation
CPN
|
$151M |
| 5 |
TIME
Time Inc.
TIME
|
$126M |
Sector Composition
| 1 | Financials | 20.1% |
| 2 | Technology | 13.18% |
| 3 | Industrials | 13.07% |
| 4 | Consumer Discretionary | 10.56% |
| 5 | Healthcare | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
US Bancorp
USB
$76B
| $252M | 0.11% |
4,995,850
+57,446
| +1% | +$2.9M |
|
152
Fulton Financial
FULT
$3.58B
| $252M | 0.11% |
14,191,377
-63,275
| -0.4% | -$1.12M |
|
153
KB Financial Group
KB
$28.6B
| $251M | 0.1% |
4,336,237
-46,521
| -1% | -$2.7M |
|
154
MetLife
MET
$54.1B
| $251M | 0.1% |
5,467,637
-41,488
| -0.8% | -$1.9M |
|
155
D.R. Horton
DHI
$50.5B
| $250M | 0.1% |
5,710,697
-16,428
| -0.3% | -$720K |
|
156
DXC Technology
DXC
$2.59B
| $250M | 0.1% |
2,482,052
-484,586
| -16% | -$48.7M |
|
157
CNO Financial Group
CNO
$3.83B
| $248M | 0.1% |
11,462,277
| – | – |
|
158
TE Connectivity
TEL
$61B
| $247M | 0.1% |
2,467,515
+1,243
| +0.1% | +$124K |
|
159
Allstate
ALL
$53.6B
| $246M | 0.1% |
2,599,343
+29,292
| +1% | +$2.78M |
|
160
Adtalem Global Education
ATGE
$4.71B
| $245M | 0.1% |
5,158,027
-33,386
| -0.6% | -$1.59M |
|
161
WESCO International
WCC
$10.7B
| $243M | 0.1% |
3,916,184
+35,429
| +0.9% | +$2.2M |
|
162
Cigna
CI
$80.3B
| $243M | 0.1% |
1,448,048
+9,966
| +0.7% | +$1.67M |
|
163
Lam Research
LRCX
$127B
| $241M | 0.1% |
1,186,966
-472,525
| -28% | -$96M |
|
164
Freeport-McMoran
FCX
$63.7B
| $241M | 0.1% |
13,718,296
-301,690
| -2% | -$5.3M |
|
165
Kemper
KMPR
$3.37B
| $241M | 0.1% |
4,227,670
-95,424
| -2% | -$5.44M |
|
166
Costco
COST
$418B
| $241M | 0.1% |
1,278,654
+30,035
| +2% | +$5.66M |
|
167
Bristol-Myers Squibb
BMY
$96B
| $241M | 0.1% |
3,804,188
-9,743
| -0.3% | -$616K |
|
168
Wintrust Financial
WTFC
$9.19B
| $240M | 0.1% |
2,788,742
-472,753
| -14% | -$40.7M |
|
169
Eastman Chemical
EMN
$8.08B
| $239M | 0.1% |
2,264,413
-8,143
| -0.4% | -$860K |
|
170
Essex Property Trust
ESS
$17.4B
| $238M | 0.1% |
989,305
+26,141
| +3% | +$6.29M |
|
171
POSCO
PKX
$15.6B
| $237M | 0.1% |
3,004,405
-23,468
| -0.8% | -$1.85M |
|
172
Darling Ingredients
DAR
$5.37B
| $236M | 0.1% |
13,664,138
-244,294
| -2% | -$4.23M |
|
173
Skywest
SKYW
$4.9B
| $235M | 0.1% |
4,324,563
-17,170
| -0.4% | -$934K |
|
174
Pultegroup
PHM
$26B
| $234M | 0.1% |
7,951,167
-1,217,641
| -13% | -$35.9M |
|
175
Korn Ferry
KFY
$3.88B
| $233M | 0.1% |
4,521,107
-107,640
| -2% | -$5.55M |
|